Stay updated with breaking news from Small Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
14.12.2022 - Small Pharma will provide SPL026 for the brain-imaging study, which seeks to explore how psychedelic-induced brain changes impact cognition, behaviour and well-beingLONDON, Dec. 14, 2022 (GLOBE NEWSWIRE) - Small Pharma Inc. (TSXV: DMT) (OTCQB: ... Seite 1
Visiongain has published a new report entitled Contract Research Organizations (CROs) 2022-2032. It includes profiles of Contract Research Organizations...
The most recent set of results, released by UK researchers yesterday in one of the world's most prestigious journals, suggest that magic mushrooms could ease depression.
Brings total to twelve granted patents across the Company’s full portfolio LONDON, Oct. 19, 2022 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT)...
Last patient dosed in Phase IIa trial for lead product candidate, SPL026 with supportive therapy for the treatment of Major Depressive Disorder Completion...